Deltex Medical Regulatory News (DEMG)

21 Oct 2005 07:00

Deltex Medical Group PLC21 October 2005 Deltex Medical Group plc Directors' Shareholdings Deltex Medical Group plc ("the Company"), the AIM listed haemodynamic monitoringcompany, announces that Finance Director, Ewan Phillips yesterday notified theCompany of a purchase of 236,842 ordinary shares at a price of 19.25 pence pershare in the market. Following the above purchase, the directors' beneficial interests are asfollows: Name of Director Number of shares Holding of shares % of enlarged issued purchased on market following issue/ share capital purchaseNigel Keen (1) - 3,863,726 5.31%Dr Edwin Snape (2) - 3,164,074 4.35%Peter Smedvig (3) - 1,098,439 1.51%Andy Hill - 42,857 0.06%Ewan Phillips 236,842 714,656 0.99%George Flouty - 244,671 0.34%Sir Duncan Nichol - 36,947 0.05% Total 236,842 9,165,370 12.61% (1) Includes 589,700 shares held as trustee and executor of Pauline ThomasCharity Will Trust. (2) Includes shares held as a director of New England Partners and associatedcompanies. (3) Includes shares held as director of Peder Smedvig Capital AS. For further information, please contact:- Deltex Medical Group plc 01243 774 837Nigel Keen, Chairman nigel.keen@deltexmedical.comAndy Hill, Chief Executive andy.hill@deltexmedical.comEwan Phillips, Finance Director ewan.phillips@deltexmedical.com Charles Stanley 0207 953 2000Philip Davies Financial DynamicsDavid Yates/John Gilbert 0207 831 3113 This information is provided by RNS The company news service from the London Stock Exchange